Key Highlights from the Board Announcement

• Acquisition of Quoted Securities: mDR Limited and its subsidiaries have acquired quoted securities totaling approximately S\$2,593,947 for the period between 30 December 2025 and 14 January 2026. This acquisition represents 1.8% of the Group’s latest audited net tangible assets.
• Sale of Quoted Securities: During the same period, the Group also sold quoted securities with a historical cost of roughly S\$82,875, equating to 0.1% of the latest audited consolidated net tangible assets.
• Changes to Investment Portfolio:
  • Aggregate cost of quoted investments increased from S\$311,464,000 to S\$311,695,000 post-acquisition.
  • This cost now makes up 210.0% of the Group’s latest audited consolidated net tangible assets, up from 209.8% prior to the acquisition.
  • Total market value of quoted investments rose slightly from S\$220,687,000 to S\$221,180,000.
  • No provision for diminution in value was made for the quoted investments, indicating that the Group does not anticipate impairment losses at this stage.
  • The latest audited consolidated net tangible assets as of 31 December 2024 stand at S\$148,431,000.

Important Considerations for Shareholders

• High Exposure to Quoted Investments: The aggregate cost of the Group’s quoted investments is more than double its latest audited net tangible assets (210.0% vs net tangible assets), highlighting a significant exposure to market fluctuations in quoted securities.
• Potential Price Sensitivity: The sizeable portfolio of quoted securities could result in material impacts to the Group’s financial position if there are significant changes in the market value of these investments. Investors should monitor market conditions and the Group’s future announcements regarding its investment portfolio.
• Recent Activity and Strategy: The acquisition and sale of quoted securities, though relatively modest in percentage terms (1.8% acquired, 0.1% sold), demonstrate active management of the Group’s investment portfolio. This could signal a strategic rebalancing or response to market opportunities.
• No Impairment Provision: The absence of any provision for diminution in value may suggest management’s confidence in the underlying value of its quoted investments, but also means that any future downturns could directly affect reported profits and asset values.

Share Price Implications

The announcement reveals that mDR Limited maintains a very high exposure to quoted securities, which is an important factor for shareholders and potential investors to consider. Any significant movement in the value of these investments could have a pronounced impact on the Group’s financial health and, consequently, its share price. While the recent transactions themselves are not large relative to the overall portfolio, the aggregate exposure and the active portfolio management could be viewed as either a risk or an opportunity, depending on market conditions. Investors are advised to pay close attention to subsequent disclosures and market developments.

Disclaimer: This article is for informational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence and consult their professional advisers before making investment decisions related to mDR Limited or any other securities.

View MDR Limited Historical chart here